Bovie Medical Corporation to Present at 29th Annual Roth Conference
March 08 2017 - 4:05PM
Business Wire
Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE:BVX),
a maker of medical devices and supplies and the developer of
J-Plasma®, a patented new surgical product, announced today that
Robert L. Gershon, Chief Executive Officer of the Company, will
present at the 29th Annual Roth Capital Conference in Dana Point,
California on Tuesday, March 14, at 3:30 p.m. Pacific Time.
To access the webcast, please go
to http://wsw.com/webcast/roth31/bvx. A replay of the webcast
and presentation will be posted following the event via Bovie
Medical’s website.
The conference will be held March 12-15, 2017 at The Ritz
Carlton and is by invitation only. Bovie Medical’s management team
will be available for one-on-one meetings. Investors interested in
arranging a meeting should contact their ROTH representative.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented new
plasma-based surgical product for cutting and coagulation.
J-Plasma® utilizes a helium ionization process to produce a stable,
focused beam of ionized gas that provides surgeons with greater
precision, minimal invasiveness and an absence of conductive
currents through the patient during surgery. Bovie Medical
Corporation is also a leader in the manufacture of a range of
electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation’s website www.boviemed.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170308006290/en/
Investor RelationsBovie Medical CorporationLynn
Morgen/Jane Searle,
212-750-5800investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Apr 2023 to Apr 2024